Showing 941 - 960 results of 1,800 for search '(( a 10 decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.19s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944
  5. 945
  6. 946
  7. 947
  8. 948
  9. 949

    Enhancing thermal and mechanical response of aluminum using nanolength scale TiC ceramic reinforcement by Reddy M.P.

    Published 2018
    “…the present work, nano-sized titanium carbide (0.5, 1.0 and 1.5 vol%) reinforced aluminum (Al) metal matrix composites were synthesized by powder metallurgy incorporating microwave sintering and hot extrusion. …”
    Get full text
    Get full text
  10. 950
  11. 951
  12. 952
  13. 953
  14. 954

    Microstructure and compressive behavior of Al-Y2O3 nanocomposites prepared by microwave-assisted mechanical alloying by Mattli M.R.

    Published 2019
    “…The Al–1.5 vol. % Y2O3 nanocomposite exhibited the best ultimate compressive strength and yielded a strength of 359 ± 7 and 111 ± 5 MPa, respectively. …”
    Get full text
    Get full text
  15. 955
  16. 956
  17. 957

    The influence of aeration scheme and aeration rate on the permeate flux for wastewater treatment using membrane bioreactors: Experimental and artificial neural network modeling by Jawad, Jasir

    Published 2021
    “…In this paper, the effect of time, aeration scheme, aeration rate, and mixed liquor suspended solid (MLSS) concentration on the permeate flux in membrane bioreactors have been studied. Aeration rates of 0.5, 1.0, and 1.5 LPM were tested with MLSS concentrations of 5, 10, and 15 g/L. …”
    Get full text
    Get full text
  18. 958
  19. 959

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  20. 960

    Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats by Kiss, K.

    Published 2016
    “…In study 4, AF43136 at 10 mg/kg decreased infarct size, similarly to the positive control CsA compared to the appropriate vehicle (39.4 ± 5.9% vs. 58.1 ± 5.4% and 45.9 ± 2.4% vs. 63.8 ± 4.1%, p < 0.05, respectively). …”
    Get full text
    Get full text